Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists

Journal of Clinical Oncology
March 20, 2013

In this study, Dr. Bach and coauthors find that patent-protected chemotherapies are used approximately 30% of the time for for off-label indications.

Read Full Article Here